Module 1 Milestone Onesouthern New Hampshire University

Module 1 – Milestone oneSouthern New Hampshire University 02:18:27 GMT -05:00According to the Ehlers-Danlos Society, Ehlers-Danlos Syndrome (EDS) is a classification of genetic disorders that can severely impact the quality of life of those affected, such as the connective tissues inside our body. As far as we know, twelve syndromes are presently involved; the condition is characterized by a range of symptoms, including jointhypermobility, abnormal scarring, joint deformities, hernias, prolapsed organs, scoliosis, and skin hyper elasticity (Ehlers-Danlos Syndrome Research Foundation, 2022). Some more infrequent variants of Ehlers-Danlos Syndrome (EDS) can impact the connective tissues in some areas, including the eyes, mouth, and cardiovascular system, or even lead to organ rupture. Many genetic markers have been identified to subtype the variety of this condition. While several genetic markers have been identified to subtype the array of this condition, the considerable diagnosed form of Ehlers-Danlos Syndrome (EDS), Hypermobile Ehlers-Danlos Syndrome, has yet to be linked to a specific genetic marker. As a result, the diagnosis and management of this condition rely heavily on the record and physical information given by the medical provider, underscoring the crucial role of healthcare professionals in managing thiscondition. This underscores the importance of healthcare professionals